MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
Haemonetics breaks annual sales record, Q4 profits up five fold
Haemonetics Corp. (NYSE:HAE) posted profits of $21.0 million, or 81 cents per diluted share, on sales of $170.0 million during the three months ended April 2. That compares with profits of $4.0 million, or 15 cents per diluted share, on sales of $169.1 million during the same period last year.
Full-year profits were $80.0 million, or $3.12 per diluted share, on sales of $676.7 million. That compares with profits of $58.4 million, or $2.24 per diluted share, on sales of $645.4 million in fiscal year 2010.
Read more
Omnicell profits shrink, revenue flat
Omnicell Inc. (NSDQ:OMCL) reported profits of $670,000, or 2 cents per diluted share, on revenue of $57.2 million during the three months ended March 31. That compares with profits of $979,000, or 3 cents per diluted share, on revenue of $57.2 million for the same period last year.
Read more
Parexel profits rise 23 percent following modest revenues bump
Parexel International Corp. (NSDQ:PRXL) reported a profit of $15.7 million, or 26 cents per diluted share, on revenue of $353.0 million during the three months ended March 31. That compares with a profit of $12.8 million, or 22 cents per diluted share, on revenue of $344.4 million during the same period last year.
Read more
Stereotaxis losses widen on shrinking sales
Stereotaxis Inc. (NSDQ:STXS) posted a loss of $9.5 million, or 17 cents per diluted share, on sales of $4.3 million during the three months ended March 31. That compares with a loss of $8.4 million, or 17 cents per diluted share, on sales of $5.2 million during the same period last year.
Read more
Hologic profits rocket
Hologic Inc. (NSDQ:HOLX) posted profits of $82.4 million, or 31 cents per diluted share, on sales of $438.7 million during the three months ended March 26. That compares with profits of $20.6 million, or 8 cents per diluted share, on sales of $418.1 million during the same period last year.
Read more
ERT revenues nearly double
eResearchTechnology Inc. (NSDQ:ERT) posted net earnings of $3.1 million, or 6 cents per diluted share, on revenue of $41.7 million during the three months ended March 31. That compares with net earnings of $1.8 million, or 4 cents per diluted share, on revenue of $21.9 million during the same period last year.
Read more
ArthroCare sales, profits rise
ArthroCare Corp. (NSDQ:ARTC) posted net earnings of $12.8 million, or 36 cents per diluted share, on revenue of $87.9 million during the three months ended March 31. That compares with net earnings of $8.8 million, or 24 cents per diluted share, on revenue of $89.1 million during the same period last year.
Read more
